GI Insights

Join Dr. Peter Buch as he explores the management of acute gastrointestinal bleeding and the periendoscopic period with anticoagulants and with Dr. Neena Abraham, Associate Medical Director at the Mayo Clinic Center for the Science of Health Care Delivery in Arizona and lead author of the joint “American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline.”

Proton pump inhibitors (PPIs) are among the 10 most widely prescribed medications, but PPI overuse has been associated with adverse events. So what is the best advice for de-prescribing PPIs, and which of our patients should remain on PPIs? Find out the answers to these and other key questions with Dr. Peter Buch and Dr. Laura Targownik, who’s the lead author of the American Gastroenterological Association’s Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors.

Over the last two decades, up to 20 percent of the population in industrialized nations have reported an abnormal physical response to food ingestion, also known as an adverse reaction to food. So what key information do we need to know about food allergies and intolerances amid this recent rise around the world? To find out, Dr. Peter Buch is joined by Dr. Frances Onyimba, Assistant Professor of Medicine at the University of Maryland School of Medicine. Together, they’ll discuss how we can better identify and diagnose food allergies and intolerances.

H. pylori testing is accessible now more than ever before. Why is this development so important? To help us understand why, Dr. David Graham, a Professor of Medicine and Gastroenterology at the Baylor College of Medicine, joins Dr. Peter Buch to discuss this availability and dive into “Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why."

In patients with cirrhosis and chronic liver disease, acute-on-chronic liver failure is emerging as a major cause of mortality. That’s why an update on precipitating factors and essential management strategies is the basis of Dr. Peter Buch’s discussion with Dr. Jasmohan Bajaj, Professor of Medicine at the Richmond VA Medical Center and lead author of the article “Acute-on-Chronic Liver Failure Clinical Guidelines,” which was published in the American Journal of Gastroenterology in February 2022.

What are some ways we can strike the perfect balance when it comes to treating our patients with GERD? To help us answer this question, Dr. Harish Gagneja from the Dell Medical School at the University of Texas joins Dr. Peter Buch to explore balanced treatment options for these patients.

Let’s escape our busy day for a moment to imagine the future of gastroenterology and to ask ourselves: How can technology make us better clinicians? Explore that very question with Drs. Peter Buch and Brennan Spiegel as they discuss the latest advances in artificial intelligence and virtual reality that are aiding both clinical practice and research efforts.

Small intestinal bacterial overgrowth (SIBO) has been recognized for years, yet the optimal method of diagnosis remains controversial. So to help clear up the controversy, Dr. Peter Buch welcomes back returning guest Dr. Alexander Perelman to talk about diagnosing and treating SIBO.

Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.

Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.